“…Also regarding luminal fillers, the second key element in bio-engineered nerve guides, a plea has been for made for new approaches, and these are currently being explored worldwide and, similarly to conduits, both biological and synthetic mate-rial may be sought (Yan et al, 2009). As regards biological fillers, these can be both entirely autologous tissues, such as a piece of muscle (Battiston et al, 2009), as well as tissue extracts, such as stem/precursor cells (Erba et al, 2010). One of the tissues that has received a great deal of attention in tissue engineering over the last years is adipose tissue due to its extensive availability, the ease of its withdrawal from the same patient and the demonstration that it possesses stem cells (Zuk et al, 2001;Stosich and Mao, 2007;Cherubino et al, 2011;Gimble and Nuttall, 2011).…”
“…Also regarding luminal fillers, the second key element in bio-engineered nerve guides, a plea has been for made for new approaches, and these are currently being explored worldwide and, similarly to conduits, both biological and synthetic mate-rial may be sought (Yan et al, 2009). As regards biological fillers, these can be both entirely autologous tissues, such as a piece of muscle (Battiston et al, 2009), as well as tissue extracts, such as stem/precursor cells (Erba et al, 2010). One of the tissues that has received a great deal of attention in tissue engineering over the last years is adipose tissue due to its extensive availability, the ease of its withdrawal from the same patient and the demonstration that it possesses stem cells (Zuk et al, 2001;Stosich and Mao, 2007;Cherubino et al, 2011;Gimble and Nuttall, 2011).…”
“…Interestingly, however, the positive effects of undifferentiated cells have also been widely reported [5,7,13,[32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51] . These investigators claim that in vitro differentiation incurs an unnecessary delay, limiting clinical applicability.…”
Section: Differentiationmentioning
confidence: 99%
“…No difference in functional, morphometric or immunohistochemistry between ADSCs and BMSCs Erba et al [45] Rat sciatic transection (10 mm gap) U Fibrin PHB conduit Lack of sufficient quantities of viable cells 14-d after transplantation; conclusion that regenerative effect due to initial growth factor boost or paracrine effect on resident cells Sun et al [51] Rat facial transection (8 mm gap) D Matrigel Decellularized allogeneic artery dADSCs persisted at repair site and integrated with regenerated tissue; conduits containing dADSCs achieved results comparable to those of SC-containing conduits and superior to matrigel-containing conduits alone; results inferior to autograft Fetal Pan et al [106] Rat sciatic crush U Fibrin glue…”
Outcomes following peripheral nerve injury remain frustratingly poor. The reasons for this are multifactorial, although maintaining a growth permissive environment in the distal nerve stump following repair is arguably the most important. The optimal environment for axonal regeneration relies on the synthesis and release of many biochemical mediators that are temporally and spatially regulated with a high level of incompletely understood complexity. The Schwann cell (SC) has emerged as a key player in this process. Prolonged periods of distal nerve stump denervation, characteristic of large gaps and proximal injuries, have been associated with a reduction in SC number and ability to support regenerating axons. Cell based therapy offers a potential therapy for the improvement of outcomes following peripheral nerve reconstruction. Stem cells have the potential to increase the number of SCs and prolong their ability to support regeneration. They may also have the ability to rescue and replenish populations of chromatolytic and apoptotic neurons following axotomy. Finally, they can be used in non-physiologic ways to preserve injured tissues such as denervated muscle while neuronal ingrowth has not yet occurred. Aside from stem cell type, careful consideration must be given to differentiation status, how stem cells are supported following transplantation and how they will be delivered to the site of injury. It is the aim of this article to review current opinions on the strategies of stem cell based therapy for the augmentation of peripheral nerve regeneration.
“…In either case, it has been suggested that these cells evoke an early response, lasting less than 14 days, suggesting that the regenerative effect observed in the repair of a 10 mm sciatic nerve defects is mediated by an initial boost of released neurotrophic factors in the regenerative microenvironment 103,104 .…”
“…These cells have been used in combination with tubular constructs either as undifferentiated cells 104 or by differentiating the cells in vitro prior to implantation in vivo 103 , with both approaches showing promising results.…”
Peripheral nerve injuries have high incidence rates, limited treatment options and poor clinical outcomes, rendering a significant socioeconomic burden. For effective peripheral nerve repair, the gap or site of injury must be structurally bridged to promote correct
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.